<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antimicrob Agents Chemother</journal-id><journal-id journal-id-type="iso-abbrev">Antimicrob. Agents Chemother</journal-id><journal-id journal-id-type="hwp">aac</journal-id><journal-id journal-id-type="pmc">aac</journal-id><journal-id journal-id-type="publisher-id">AAC</journal-id><journal-title-group><journal-title>Antimicrobial Agents and Chemotherapy</journal-title></journal-title-group><issn pub-type="ppub">0066-4804</issn><issn pub-type="epub">1098-6596</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4862533</article-id><article-id pub-id-type="pmid">26953212</article-id><article-id pub-id-type="publisher-id">02949-15</article-id><article-id pub-id-type="doi">10.1128/AAC.02949-15</article-id><article-categories><subj-group subj-group-type="heading"><subject>Mechanisms of Resistance</subject></subj-group></article-categories><title-group><article-title>First Report of <italic>cfr</italic>-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> Staphylococcal Cassette Chromosome <italic>mec</italic> Type IV Clone</article-title><alt-title alt-title-type="running-head"><italic>cfr</italic> in ST22-MRSA-IV</alt-title><alt-title alt-title-type="short-authors">Shore et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shore</surname><given-names>Anna C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lazaris</surname><given-names>Alexandros</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kinnevey</surname><given-names>Peter M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Brennan</surname><given-names>Orla M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Brennan</surname><given-names>Gr&#225;inne I.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>O'Connell</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fe&#223;ler</surname><given-names>Andrea T.</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schwarz</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1797-2888</contrib-id><name><surname>Coleman</surname><given-names>David C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>Microbiology Research Unit, Dublin Dental University Hospital, University of Dublin, Trinity College Dublin, Dublin, Ireland</aff><aff id="aff2"><label>b</label>National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland</aff><aff id="aff3"><label>c</label>Department of Clinical Microbiology, School of Medicine, Trinity College Dublin, St. James's Hospital, Dublin, Ireland</aff><aff id="aff4"><label>d</label>Institute of Farm Animal Genetics, Friedrich Loeffler Institut, Neustadt-Mariensee, Germany</aff></contrib-group><author-notes><corresp id="cor1">Address correspondence to David C. Coleman, <email>david.coleman@dental.tcd.ie</email>.</corresp><fn fn-type="equal"><p>A.C.S. and A.L. contributed equally to this work.</p></fn><fn fn-type="other"><p><bold>Citation</bold> Shore AC, Lazaris A, Kinnevey PM, Brennan OM, Brennan GI, O'Connell B, Fe&#223;ler AT, Schwarz S, Coleman DC. 2016. First report of <italic>cfr</italic>-carrying plasmids in the pandemic sequence type 22 methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> staphylococcal cassette chromosome <italic>mec</italic> type IV clone. Antimicrob Agents Chemother 60:3007&#8211;3015. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.02949-15">10.1128/AAC.02949-15</ext-link>.</p></fn></author-notes><pub-date pub-type="epreprint"><day>7</day><month>3</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>22</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>4</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the							<pub-date pub-type="epub"/>. --><volume>60</volume><issue>5</issue><fpage>3007</fpage><lpage>3015</lpage><history><date date-type="received"><day>9</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>29</day><month>2</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#169; 2016 Shore et al.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Shore et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="zac00516003007.pdf"/><abstract><p>Linezolid is often the drug of last resort for serious methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> (MRSA) infections. Linezolid resistance is mediated by mutations in 23S rRNA and genes for ribosomal proteins; <italic>cfr</italic>, encoding phenicol, lincosamide, oxazolidinone, pleuromutilin, and streptogramin A (PhLOPS<sub>A</sub>) resistance; its homologue <italic>cfr</italic>(B); or <italic>optrA</italic>, conferring oxazolidinone and phenicol resistance. Linezolid resistance is rare in <named-content content-type="genus-species">S. aureus</named-content>, and <italic>cfr</italic> is even rarer. This study investigated the clonality and linezolid resistance mechanisms of two MRSA isolates from patients in separate Irish hospitals. Isolates were subjected to <italic>cfr</italic> PCR, PhLOPS<sub>A</sub> susceptibility testing, 23S rRNA PCR and sequencing, DNA microarray profiling, <italic>spa</italic> typing, pulsed-field gel electrophoresis (PFGE), plasmid curing, and conjugative transfer. Whole-genome sequencing was used for single-nucleotide variant (SNV) analysis, multilocus sequence typing, L protein mutation identification, <italic>cfr</italic> plasmid sequence analysis, and <italic>optrA</italic> and <italic>cfr</italic>(B) detection. Isolates M12/0145 and M13/0401 exhibited linezolid MICs of 64 and 16 mg/liter, respectively, and harbored identical 23S rRNA and L22 mutations, but M12/0145 exhibited the mutation in 2/6 23S rRNA alleles, compared to 1/5 in M13/0401. Both isolates were sequence type 22 MRSA staphylococcal cassette chromosome <italic>mec</italic> type IV (ST22-MRSA-IV)/<italic>spa</italic> type t032 isolates, harbored <italic>cfr</italic>, exhibited the PhLOPS<sub>A</sub> phenotype, and lacked <italic>optrA</italic> and <italic>cfr</italic>(B). They differed by five PFGE bands and 603 SNVs. Isolate M12/0145 harbored <italic>cfr</italic> and <italic>fexA</italic> on a 41-kb conjugative pSCFS3-type plasmid, whereas M13/0401 harbored <italic>cfr</italic> and <italic>lsa</italic>(B) on a novel 27-kb plasmid. This is the first report of <italic>cfr</italic> in the pandemic ST22-MRSA-IV clone. Different <italic>cfr</italic> plasmids and mutations associated with linezolid resistance in genotypically distinct ST22-MRSA-IV isolates highlight that prudent management of linezolid use is essential.</p></abstract><funding-group><funding-statement>This work was principally supported by the Microbiology Research Unit, Dublin Dental University Hospital. Part of this study was supported by the German Federal Ministry of Education and Research (BMBF) provided through the German Aerospace Center (DLR), grant number 01KI1301D (MedVet-Staph) to Stefan Schwarz. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="64"/><page-count count="9"/><word-count count="8319"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>INTRODUCTION</title><p>The oxazolidinone antimicrobial agent linezolid was first introduced into clinical practice in 2000, and it quickly became the drug of last resort to treat skin and soft tissue infections and pneumonia caused by multidrug-resistant Gram-positive cocci, including methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> (MRSA). Linezolid binds to the A site of the peptidyl transferase center in the V domain of the 23S rRNA component of the 50S subunit of the bacterial ribosome (<xref rid="B1" ref-type="bibr">1</xref>). Binding of linezolid interferes with the correct positioning of aminoacyl tRNA on the ribosome, which prevents the formation of the initiation complex and thus inhibits the initiation of protein synthesis (<xref rid="B1" ref-type="bibr">1</xref>).</p><p>Resistance to linezolid is predominantly mediated by (i) mutations in the drug target site (domain V of the six 23S rRNA alleles) or in the genes encoding the 50S ribosomal proteins (L3, L4, and L22) that have been speculated to result in the impairment of linezolid binding and/or (ii) acquisition of the transferable linezolid resistance gene <italic>cfr</italic> (<xref rid="B2" ref-type="bibr">2</xref><xref ref-type="bibr" rid="B3">&#8211;</xref><xref rid="B4" ref-type="bibr">4</xref>). The <italic>cfr</italic> gene encodes a methyltransferase that catalyzes the posttranscriptional methylation of adenosine at nucleotide position 2503 (<named-content content-type="genus-species">Escherichia coli</named-content> numbering) in 23S rRNA, thus interfering with the binding of linezolid to its target (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). However, due to overlapping binding sites, <italic>cfr</italic> methylation also affects the binding of four other classes of antimicrobial agents and results in the multiresistance PhLOPS<sub>A</sub> phenotype, i.e., resistance to <underline>ph</underline>enicols, <underline>l</underline>incosamides, <underline>o</underline>xazolidinones, <underline>p</underline>leuromutilins and <underline>s</underline>treptogramin <underline>A</underline> compounds (<xref rid="B6" ref-type="bibr">6</xref>). Recently, a novel plasmid-located ABC transporter gene, <italic>optrA</italic>, conferring resistance to linezolid and phenicols, and a <italic>cfr</italic> homologue, <italic>cfr</italic>(B), have also been identified (<xref rid="B7" ref-type="bibr">7</xref><xref ref-type="bibr" rid="B8">&#8211;</xref><xref rid="B9" ref-type="bibr">9</xref>).</p><p>The <italic>cfr</italic> gene was first reported in a bovine <named-content content-type="genus-species">Staphylococcus sciuri</named-content> isolate in 1997 and was subsequently found in many different staphylococcal species, including methicillin-susceptible <named-content content-type="genus-species">S. aureus</named-content> (MSSA), MRSA, and coagulase-negative and coagulase-variable (<named-content content-type="genus-species">Staphylococcus hyicus</named-content>) staphylococci, as well as in <named-content content-type="genus-species">Bacillus</named-content>, <named-content content-type="genus-species">Enterococcus</named-content>, <named-content content-type="genus-species">Streptococcus</named-content>, <named-content content-type="genus-species">Macrococcus</named-content>, <named-content content-type="genus-species">Jeotgalicoccus</named-content>, <named-content content-type="genus-species">Proteus</named-content>, and <named-content content-type="genus-species">Escherichia</named-content> species (<xref rid="B10" ref-type="bibr">10</xref><xref ref-type="bibr" rid="B11">&#8211;</xref><xref rid="B12" ref-type="bibr">12</xref>). It has been detected in isolates from humans, livestock, meat products, and the environment and has been identified on a variety of plasmids, although chromosomal locations have also been reported (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B13" ref-type="bibr">13</xref>). In some instances, different bacterial species as well as a variety of animal and human hosts have been found to harbor similar <italic>cfr</italic> plasmids or genetic environments, highlighting the ability of <italic>cfr</italic> to spread (<xref rid="B10" ref-type="bibr">10</xref>). Specific insertion sequences (ISs) have been shown to play a role in <italic>cfr</italic> mobility and integration into different plasmid types, and <italic>cfr</italic> is often colocated with other resistance determinants, allowing for the coselection of <italic>cfr</italic> (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>Linezolid resistance remains relatively rare among <named-content content-type="genus-species">S. aureus</named-content> isolates, and <italic>cfr</italic> is even more so (<xref rid="B14" ref-type="bibr">14</xref><xref ref-type="bibr" rid="B15">&#8211;</xref><xref rid="B16" ref-type="bibr">16</xref>). The earliest reported <italic>cfr</italic>-mediated linezolid-resistant <named-content content-type="genus-species">S. aureus</named-content> isolates were two sequence type 5 (ST5) MRSA isolates recovered in 2005 from two patients in hospitals in Colombia and Indianapolis, IN, respectively (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). The <italic>cfr</italic> gene was subsequently reported in a small number of sporadically occurring <named-content content-type="genus-species">S. aureus</named-content> isolates, predominantly MRSA, from both animals and humans, belonging to a range of genotypes, including the multilocus sequence type (MLST) clonal complex 5 (CC5) (STs 627, 228, 5, 125, and 1788), CC6/ST6, CC8/ST8 (ST8 MRSA staphylococcal cassette chromosome <italic>mec</italic> [SCC<italic>mec</italic>] type IV [ST8-MRSA-IV]/USA300), CC9 (STs 9 and 63), and CC398/ST398 as well as in association with an outbreak of an unspecified MRSA clone in a Spanish hospital in 2008 (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B19" ref-type="bibr">19</xref><xref ref-type="bibr" rid="B20">&#8211;</xref><xref rid="B32" ref-type="bibr">32</xref>). Although two studies localized <italic>cfr</italic> to the <named-content content-type="genus-species">S. aureus</named-content> chromosome (one within the SCC<italic>mec</italic> type IVb J1 region [<xref rid="B23" ref-type="bibr">23</xref>] and one within 23S rRNA allele 4 [<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B33" ref-type="bibr">33</xref>]), it has predominantly been reported to be located on a diverse range of plasmids (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>In Ireland, only one <italic>cfr</italic>-positive MRSA isolate has been reported to date (USA300/ST8-MRSA-IVa), in which <italic>cfr</italic> was located on a novel plasmid (pSCFS7) together with a second phenicol resistance gene, <italic>fexA</italic>, via the integration of <italic>cfr</italic> into the <italic>fexA</italic>-carrying transposon Tn<italic>558</italic> (<xref rid="B20" ref-type="bibr">20</xref>). Recently, <italic>cfr</italic> was also detected in methicillin-resistant <named-content content-type="genus-species">Staphylococcus epidermidis</named-content> (MRSE) clinical isolates from Ireland, although the possible plasmid location of <italic>cfr</italic> in these isolates was not reported (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>).</p><p>ST22-MRSA-IV is a pandemic MRSA clone that is endemic in hospitals in Ireland and the United Kingdom and predominates among nosocomial MRSA isolates in several other European countries, Asia, and Australia (<xref rid="B36" ref-type="bibr">36</xref><xref ref-type="bibr" rid="B37">&#8211;</xref><xref rid="B41" ref-type="bibr">41</xref>). It has also been reported sporadically in the United States and South America (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Although mutational resistance to linezolid has been reported in ST22-MRSA-IV isolates, <italic>cfr</italic> has not been reported (<xref rid="B44" ref-type="bibr">44</xref>). During 2012 and 2013, two epidemiologically unrelated linezolid-resistant MRSA isolates were recovered from two patients in two separate Irish hospitals and were submitted to the Irish National MRSA Reference Laboratory. The purpose of this study was to investigate the genetic basis of linezolid resistance and the genetic relatedness of these isolates. This study reports the first identification of <italic>cfr</italic> in association with two distinct <italic>cfr</italic> plasmids in two genetically distinct ST22-MRSA-IV isolates.</p></sec><sec sec-type="materials|methods" id="sec2"><title>MATERIALS AND METHODS</title><sec id="sec2-1"><title>Bacterial isolates.</title><p>Two linezolid-resistant MRSA isolates recovered from patients in two separate Irish hospitals &#8764;250 km apart, one in 2012 in Cork (M12/0145) and the other in 2013 in Dublin (M13/0401), were investigated. Isolate M12/0145 was recovered from a sputum sample, and the patient had previously been treated with linezolid. Isolate M13/0401 was recovered from an abdominal wound swab, and no data were available on linezolid treatment of this patient. Isolates were initially tentatively identified as <named-content content-type="genus-species">S. aureus</named-content> by using the tube coagulase test, as described previously (<xref rid="B45" ref-type="bibr">45</xref>), and as cefoxitin and linezolid resistant by disk diffusion using European Committee on Antimicrobial Susceptibility Testing (EUCAST) methodologies and interpretive criteria (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). Definitive identification of isolates as <named-content content-type="genus-species">S. aureus</named-content> was performed by DNA microarray profiling (see below). Plasmid-free novobiocin-resistant <named-content content-type="genus-species">S. aureus</named-content> strain XU21 was used as a plasmid recipient in filter-mating experiments (<xref rid="B48" ref-type="bibr">48</xref>). Isolates were stored at &#8722;80&#176;C on Protect Bacterial Preservation System cryogenic beads in individual preserver vials (Technical Services Consultants Ltd., Heywood, United Kingdom).</p></sec><sec id="sec2-2"><title>Investigation of isolates for the PhLOPS<sub>A</sub> phenotype.</title><p>The two linezolid-resistant MRSA isolates (M12/0145 and M13/0401); their respective <italic>cfr</italic>-negative, plasmid-cured derivatives (M12/0145-C1 and M13/0401-C1); and the <italic>cfr</italic>-positive transconjugant derivative of XU21 (M12/0145/XU21-T1), generated following mating experiments between M12/0145 and the recipient strain XU21, were investigated for the PhLOPS<sub>A</sub> phenotype. Chloramphenicol, clindamycin, and linezolid MICs were determined by using the Vitek 2 system (AST P580 panel, susceptibility tests for Gram-positive bacteria; bioM&#233;rieux, Basingstoke, Hampshire, United Kingdom) according to the manufacturer's instructions. Tiamulin MICs were determined by using Etest strips ranging from 0.002 mg/liter to 32 mg/liter (Liofilchem, Roseto degli Abruzzi, Italy). Virginiamycin M<sub>1</sub> MICs were determined by broth microdilution (range, 1 mg/liter to 256 mg/liter) using Clinical and Laboratory Standards Institute (CLSI) methodologies and virginiamycin M<sub>1</sub> powder (Sigma-Aldrich Ireland Ltd., Arklow, County Wicklow, Ireland) (<xref rid="B49" ref-type="bibr">49</xref>). The absence of the PhLOPS<sub>A</sub> phenotype in plasmid-free <named-content content-type="genus-species">S. aureus</named-content> recipient strain XU21 was determined as described previously (<xref rid="B20" ref-type="bibr">20</xref>).</p></sec><sec id="sec2-3"><title>Additional antimicrobial susceptibility testing.</title><p>The two linezolid-resistant MRSA parental isolates, their cured and transconjugant derivatives, and recipient strain XU21 also underwent antimicrobial susceptibility testing against a panel of 23 antimicrobial agents and heavy metals according to EUCAST methodologies (<xref rid="B47" ref-type="bibr">47</xref>), using previously described interpretive criteria and quality control strains (<xref rid="B50" ref-type="bibr">50</xref>). The 23 agents tested were amikacin, ampicillin, cadmium acetate, chloramphenicol, ciprofloxacin, erythromycin, ethidium bromide, fusidic acid, gentamicin, kanamycin, lincomycin, mercuric chloride, mupirocin, neomycin, phenyl mercuric acetate, rifampin, spectinomycin, streptomycin, sulfonamide, tetracycline, tobramycin, trimethoprim, and vancomycin.</p></sec><sec id="sec2-4"><title>Genotyping.</title><p>The two linezolid-resistant MRSA isolates and their cured derivatives underwent <italic>spa</italic> typing. Genomic DNA for <italic>spa</italic> typing was extracted from each isolate/derivative by using enzymatic lysis and the DNeasy blood and tissue kit (Qiagen, Crawley, West Sussex, United Kingdom) according to the manufacturer's instructions. PCRs were performed by using GoTaq Flexi DNA polymerase (Promega Corporation, Madison, WI, USA), according to the manufacturer's instructions, using the primers and thermal cycling conditions described by the European Network of Laboratories for Sequence Based Typing of Microbial Pathogens (SeqNet) (<ext-link ext-link-type="uri" xlink:href="http://www.seqnet.org/">http://www.seqnet.org/</ext-link>) and a G-storm GS1 thermocycler (Applied Biosystems, Foster City, CA). PCR products were visualized by conventional agarose gel electrophoresis and were purified by using the GenElute PCR cleanup kit (Sigma-Aldrich). Sequencing was performed commercially by Source Bioscience (Tramore, Waterford, Ireland), using an ABI 3730xl Sanger sequencing platform. Ridom StaphType version 1.3 software (Ridom GmBH, W&#252;rzburg, Germany) was used for <italic>spa</italic> sequence analysis and assignment of <italic>spa</italic> types (<xref rid="B51" ref-type="bibr">51</xref>). The two linezolid-resistant MRSA isolates also underwent pulsed-field gel electrophoresis (PFGE) using SmaI, as described previously (<xref rid="B52" ref-type="bibr">52</xref>).</p><p>The StaphyType DNA microarray kit (Alere Technologies, Jena, Germany) was used for confirmation of isolates as <named-content content-type="genus-species">S. aureus</named-content>, for assigning isolates and derivatives to MLST STs and/or CCs and SCC<italic>mec</italic> types, and for detecting antimicrobial resistance genes (including <italic>cfr</italic>) and virulence genes (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>). The DNA microarray procedures were performed according to the manufacturer's instructions, and the primers, probes, and protocols were described previously in detail (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>). Genomic DNA for use with the DNA microarray kit was extracted from isolates and derivatives by enzymatic lysis using the buffers and solutions provided with the StaphyType kit and the Qiagen DNeasy blood and tissue kit (Qiagen, Crawley, West Sussex, United Kingdom). DNA microarray profiling of plasmid-free <named-content content-type="genus-species">S. aureus</named-content> recipient strain XU21 was performed in a previous study (<xref rid="B20" ref-type="bibr">20</xref>).</p></sec><sec id="sec2-5"><title>Plasmid analysis and whole-genome sequencing.</title><p>Plasmid curing and filter-mating conjugative transfer experiments were performed as described previously (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>). The two linezolid-resistant parental MRSA isolates underwent whole-genome sequencing (WGS) in order to (i) determine the genetic organizations of <italic>cfr</italic> and its surrounding regions in these isolates and compare them to each other and to those described previously; (ii) determine the number of single-nucleotide variants (SNVs) between the two linezolid-resistant MRSA isolates; (iii) assign the two linezolid-resistant MRSA isolates to MLST STs, as the DNA microarray assigned these isolates only to MLST CCs; (iv) identify any possible linezolid resistance-associated ribosomal target site mutations in the <italic>rplC</italic> (L3), <italic>rplD</italic> (L4), and <italic>rplV</italic> (L22) genes in the two <italic>cfr</italic>-positive MRSA isolates; and (v) detect <italic>optrA</italic> and <italic>cfr</italic>(B). The 23S rRNA alleles were amplified by PCR as described previously (<xref rid="B57" ref-type="bibr">57</xref>), and sequencing reactions were performed by Source Bioscience.</p><p>For both isolates, WGS was performed by using a MiSeq desktop sequencer (Illumina, Essex, United Kingdom), and, for M13/0401 only, WGS was also performed by using a PacBio RS sequencing system (Pacific Biosciences, USA) with subsequent <underline>H</underline>ierarchal <underline>G</underline>enome <underline>A</underline>ssembly <underline>P</underline>rocess (HGAP.3) analysis (The Genome Analysis Centre [TGAC], Norwich, United Kingdom), to confirm the genetic organization of the novel <italic>cfr</italic> plasmid identified. Genomic DNA for WGS was extracted from both isolates by using the Qiagen DNeasy blood and tissue kit. For the MiSeq analysis, WGS libraries were prepared by using Nextera XT library preparation reagents (Illumina). Reads generated by using the MiSeq system were checked for quality, trimmed, and assembled into contigs by using the Velvet <italic>de novo</italic> assembler, which is incorporated into SeqSphere version 2.3 software (Ridom). For PacBio WGS, genomic DNA was checked for quality and concentration according to TGAC guidelines. Contigs generated from both WGS methods were analyzed separately by using the BioNumerics Genome Analysis Tool (GAT) plug-in (version 7.5; Applied Maths, Sint-Martens-Latem, Belgium), the Artemis genome browser and annotation tool (<xref rid="B58" ref-type="bibr">58</xref>), and BLAST software (<ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>). Open reading frames (ORFs) were predicted by using the BioNumerics annotation tool and BLAST software packages. ORFs were aligned with best-fitting matches in GenBank, and the locations of start and stop codons were checked for consistency and modified if required. Any gaps identified in the <italic>cfr</italic> region in the isolates were closed by PCR and sequencing using primers based on the surrounding contigs followed by amplimer sequencing at Source Bioscience. Data were analyzed and overlapping sequences were assembled by using BioNumerics. The genetic organization of the <italic>cfr</italic> region in each isolate was confirmed by using PCR and the primers listed in Table S1 in the supplemental material. For M12/0145, this was done for the &#916;<italic>tnpA-fexA</italic> region encompassing <italic>cfr</italic> and not the entire <italic>cfr</italic>-carrying plasmid in this isolate due to its high similarity to a previously described <italic>cfr</italic> plasmid. For M13/0401, this was done for the entire plasmid, as it was distinct from those described previously.</p><p>MiSeq WGS data for M13/0401 were also resequenced against the <italic>de novo</italic> MiSeq assembly of isolate M12/0145 followed by alignment, and SNVs were identified and confirmed if they exhibited &#8805;40&#215; coverage; i.e., each SNV was covered by at least 40 reads, thereby avoiding ambiguous SNVs and increasing the confidence in the SNV validity. All synonymous and nonsynonymous mutations were included. Insertions and deletions (indels) and repetitive regions were excluded.</p></sec><sec id="sec2-6"><title>Nucleotide sequence accession numbers.</title><p>The nucleotide sequences from M12/0145 and M13/0401 have been deposited in GenBank under the following accession numbers: <ext-link ext-link-type="gen" xlink:href="KU521355">KU521355</ext-link> and <ext-link ext-link-type="gen" xlink:href="KU510528">KU510528</ext-link> for <italic>cfr</italic>-carrying plasmids in M12/0145 and M13/0401, respectively; <ext-link ext-link-type="gen" xlink:href="KU510534">KU510534</ext-link> for allele 1, <ext-link ext-link-type="gen" xlink:href="KU510535">KU510535</ext-link> for allele 2, <ext-link ext-link-type="gen" xlink:href="KU510536">KU510536</ext-link> for allele 3, <ext-link ext-link-type="gen" xlink:href="KU510537">KU510537</ext-link> for allele 4, <ext-link ext-link-type="gen" xlink:href="KU510538">KU510538</ext-link> for allele 5, and <ext-link ext-link-type="gen" xlink:href="KU510539">KU510539</ext-link> for allele 6 of the 23S rRNA V domain of M12/0145; <ext-link ext-link-type="gen" xlink:href="KU510529">KU510529</ext-link> for allele 1, <ext-link ext-link-type="gen" xlink:href="KU510530">KU510530</ext-link> for allele 2, <ext-link ext-link-type="gen" xlink:href="KU510531">KU510531</ext-link> for allele 3, <ext-link ext-link-type="gen" xlink:href="KU510532">KU510532</ext-link> for allele 4, and <ext-link ext-link-type="gen" xlink:href="KU510533">KU510533</ext-link> for allele 5 of the 23S rRNA V domain of M13/0401; and <ext-link ext-link-type="gen" xlink:href="KU510541">KU510541</ext-link> and <ext-link ext-link-type="gen" xlink:href="KU510540">KU510540</ext-link> for <italic>rplV</italic> (L22) in M12/0145 and M13/0401, respectively.</p></sec></sec><sec sec-type="results" id="sec3"><title>RESULTS</title><sec id="sec3-1"><title>Phenotypic and genotypic characteristics of linezolid-resistant MRSA.</title><p>Both isolates M12/0145 and M13/0401 were assigned to ST22-MRSA-IV and <italic>spa</italic> type t032. Each isolate exhibited the PhLOPS<sub>A</sub> phenotype with linezolid MICs of 64 mg/liter (M12/0145) and 16 mg/liter (M13/0401) (<xref ref-type="table" rid="T1">Table 1</xref>). Both isolates lacked <italic>optrA</italic> and <italic>cfr</italic>(B) but harbored <italic>cfr</italic>, and one isolate (M12/0145) also harbored the phenicol exporter gene <italic>fexA</italic> (<xref ref-type="table" rid="T1">Table 1</xref>). The isolates differed by five bands in the PFGE analysis and 603 SNVs following WGS analysis (MiSeq coverages of 131&#215; and 170&#215; for M12/0145 and M13/0401, respectively). Both <italic>cfr</italic>-positive MRSA isolates also exhibited resistance to ampicillin, erythromycin, lincomycin, ciprofloxacin, and fusidic acid and carried the resistance genes <italic>blaZ</italic> and <italic>erm</italic>(C). Isolate M13/0401 was also resistant to rifampin (<xref ref-type="table" rid="T1">Table 1</xref>). Both isolates harbored the enterotoxin C gene <italic>sec</italic> and the enterotoxin gene cluster <italic>egc</italic> but differed by the presence of immune evasion complex (IEC) genes in isolate M12/0145 (<xref ref-type="table" rid="T1">Table 1</xref>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Phenotypic and genotypic characteristics of the parental linezolid-resistant ST22&#8211;MRSA-IV isolates and their cured and transconjugant derivatives</p></caption><table-wrap-foot><fn fn-type="other" id="T1F1"><label>a</label><p>M12/0145 and M13/0401 are the <italic>cfr</italic>-positive parental isolates. Cured derivatives are indicated with &#8220;C1&#8221; after the parental isolate designations. The <italic>cfr</italic>- and <italic>fexA</italic>-positive transconjugant derivative M12/0145/XU21-T1 was generated by filter mating using M12/0145 as the plasmid donor and XU21 as the plasmid recipient. XU21 was the plasmid-free recipient strain used in conjugation experiments.</p></fn><fn fn-type="other" id="T1F2"><label>b</label><p>The phenotypic and genotypic characteristics (apart from resistance to antimicrobial agents outside the PhLOPS<sub>A</sub> phenotype) of plasmid-free <named-content content-type="genus-species">S. aureus</named-content> recipient strain XU21 were determined in a previous study (<xref rid="B20" ref-type="bibr">20</xref>).</p></fn><fn fn-type="other" id="T1F3"><label>c</label><p>Resistance to phenicols (chloramphenicol [CHL]), lincosamides (clindamycin [CLI]), oxazolidinones (linezolid [LZD]), pleuromutilins (tiamulin [TIA]), and streptogramin A compounds (virginiamycin [VIR]) is indicative of the PhLOPS<sub>A</sub> phenotype.</p></fn><fn fn-type="other" id="T1F4"><label>d</label><p>The resistance of each isolate to the following antimicrobial agents was also determined: amikacin, ampicillin (AMP), cadmium acetate, ciprofloxacin (CIP), ethidium bromide, erythromycin (ERM), fusidic acid (FUC), gentamicin, kanamycin, lincomycin (LIN), mercuric chloride, mupirocin, neomycin, phenyl mercuric acetate, rifampin (RIF), sulfonamide, tetracycline, tobramycin, trimethoprim, and vancomycin.</p></fn><fn fn-type="other" id="T1F5"><label>e</label><p>All resistance genes, apart from <italic>lsa</italic>(B), which is indicated in square brackets, were detected by DNA microarray profiling using the StaphyType kit (Alere). <italic>lsa</italic>(B) was detected in isolate M13/0401 in close proximity to <italic>cfr</italic> from the whole-genome sequence.</p></fn><fn fn-type="abbr" id="T1F6"><label>f</label><p>ND, not determined.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec3-2"><title>Characterization of the genetic environment of <italic>cfr</italic> in ST22-MRSA-IV isolates.</title><p>Whole-genome sequence analysis as well as results from plasmid-curing experiments indicated that <italic>cfr</italic> was plasmid located in both ST22-MRSA-IV isolates. <italic>cfr</italic>-positive isolate M13/0401 was successfully cured of <italic>cfr</italic>, whereas <italic>cfr</italic>- and <italic>fexA</italic>-positive isolate M12/0145 was successfully cured of both genes (<xref ref-type="table" rid="T1">Table 1</xref>). Cured derivatives of both isolates M12/0145-C1 and M13/0401-C1 lacked the PhLOPS<sub>A</sub> phenotype but were otherwise indistinguishable from their respective parental isolates in terms of antimicrobial resistance phenotype, antimicrobial resistance and virulence genes detected by using DNA microarray analysis, and MLST SCC<italic>mec</italic> and <italic>spa</italic> types (<xref ref-type="table" rid="T1">Table 1</xref>). While the <italic>cfr</italic>-negative cured derivative M13/0401-C1 was linezolid susceptible, the <italic>cfr</italic>- and <italic>fexA</italic>-negative cured derivative M12/0145-C1 exhibited linezolid resistance, with a linezolid MIC of 8 mg/liter (<xref ref-type="table" rid="T1">Table 1</xref>), but this was lower than the corresponding linezolid MIC exhibited by its <italic>cfr</italic>-positive parental isolate (M12/0145 linezolid MIC of 64 mg/liter) (<xref ref-type="table" rid="T1">Table 1</xref>).</p><p>A transconjugant derivative of <named-content content-type="genus-species">S. aureus</named-content> recipient strain XU21 (M12/0145/XU21-T1) (<xref ref-type="table" rid="T1">Table 1</xref>) was obtained by using MRSA isolate M12/0145 as the donor; it exhibited the PhLOPS<sub>A</sub> phenotype and was otherwise indistinguishable from XU21 apart from the presence of <italic>cfr</italic> and <italic>fexA</italic> (<xref ref-type="table" rid="T1">Table 1</xref>). Several separate attempts to generate a transconjugant derivative of XU21 using M13/0401 as the donor were unsuccessful. In contrast, isolates M05/0060 (a <italic>cfr</italic>-positive ST8-MRSA-IVa isolate and the only previously described <italic>cfr</italic>-positive MRSA isolate from Ireland) (<xref rid="B20" ref-type="bibr">20</xref>) and M12/0145 (<italic>cfr</italic>-positive ST22-MRSA-IV isolate) (this study), shown to harbor conjugative <italic>cfr</italic> plasmids, consistently yielded <italic>cfr</italic>-positive transconjugants when used as positive controls.</p><p>Based on the whole-genome sequence, the <italic>cfr</italic> plasmids in M12/0145 and M13/0401 were found to differ substantially from each other (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="fig" rid="F1">e</xref>) and were identified on four and two contigs, respectively, following MiSeq WGS and, for M13/0401 only, on one contig following PacBio sequencing (PacBio coverage for M13/0401 of 100&#215;). For isolate M12/0145, the <italic>cfr</italic>-carrying plasmid was 41,587 bp in size, and it was most similar in size and genetic organization to the previously reported 39-kb <italic>cfr</italic>-carrying plasmid pSA737 in an MRSA ST239 strain (GenBank accession no. <ext-link ext-link-type="gen" xlink:href="KC206006">KC206006</ext-link>; 94% DNA sequence homology). In fact, the genetic organization of the <italic>cfr</italic> region in M12/0145 was very similar to that described previously for pSA737/pSCFS3-like <italic>cfr</italic> plasmids from a diverse range of staphylococcal species from a variety of human and animal hosts (see Table S2 in the supplemental material). The region surrounding <italic>cfr</italic> in all of these plasmids, and in M12/0145 in the present study, consists of an IS<italic>21</italic>-like element (IS<italic>21-558</italic>) and <italic>cfr</italic> inserted into the <italic>fexA</italic>-carrying transposon Tn<italic>558</italic>, resulting in a truncation of the Tn<italic>558</italic> transposase genes <italic>tnpA</italic> and <italic>tnpB</italic> (<xref ref-type="fig" rid="F1">Fig. 1a</xref> to <xref ref-type="fig" rid="F1">d</xref>). The transposase genes &#916;<italic>tnpB</italic> (&#916; indicates a truncation) and <italic>tnpC</italic>, <italic>orf138</italic> (encoding a putative oxidoreductase), and <italic>fexA</italic> are located downstream of <italic>cfr</italic>, and <italic>orf2</italic>, IS<italic>21-558</italic> (consisting of two overlapping ORFs for <italic>istA</italic> and <italic>istB</italic>), and &#916;<italic>tnpA</italic> are located upstream of <italic>cfr</italic> (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="fig" rid="F1">b</xref>). The DNA sequences of the <italic>cfr</italic> region in M12/0145 and the <italic>cfr</italic> region in pSA737 differed only by a deletion of a thymine (T) nucleotide base in the intergenic region between <italic>orf2</italic> and <italic>cfr</italic> in M12/0145. However, beyond the <italic>cfr</italic> region, the only difference identified was a 2,326-bp region in M12/0145, located ca. 8 kb downstream of <italic>cfr</italic>, that is not present in pSA737. This region in M12/0145 consisted of a transposase gene and an <italic>istB</italic>-like gene with 48% DNA sequence homology to <italic>istB</italic> that may be involved in transposition.</p><fig id="F1" orientation="portrait" position="float"><label>FIG 1</label><caption><p>Schematic representation of the <italic>cfr</italic>-containing regions of ST22-MRSA-IV isolates M12/0145 (a) and M13/0401 (e) identified in the present study (surrounded by boxes [blue outline]) and previously described comparator plasmids and transposons, including pSA737 (GenBank accession no. <ext-link ext-link-type="gen" xlink:href="KC206006">KC206006</ext-link>) (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>) (b), Tn<italic>558</italic> (accession no. <ext-link ext-link-type="gen" xlink:href="AJ715531">AJ715531</ext-link>) (<xref rid="B4" ref-type="bibr">4</xref>) (c), pSCFS7 (accession no. <ext-link ext-link-type="gen" xlink:href="FN995111">FN995111</ext-link>, <ext-link ext-link-type="gen" xlink:href="FN995110">FN995110</ext-link>, and <ext-link ext-link-type="gen" xlink:href="FR675942">FR675942</ext-link>) (<xref rid="B20" ref-type="bibr">20</xref>) (d), and p12-00322 (accession no. <ext-link ext-link-type="gen" xlink:href="KM521836">KM521836</ext-link>) (<xref rid="B59" ref-type="bibr">59</xref>) (f). Arrows indicate the direction of transcription of each ORF. Insertion sequence elements are surrounded by a box (black outline). Each gene or group of genes is represented by a different color; i.e., red indicates <italic>cfr</italic>, orange indicates antibiotic resistance genes other than <italic>cfr</italic>, green indicates IS<italic>21-558</italic> transposition genes, blue indicates other transposition genes, and black indicates genes (<italic>hyp</italic>) and ORFs encoding hypothetical proteins. Horizontal lines between ORFs indicate intergenic regions.</p></caption><graphic xlink:href="zac0051651570001"/></fig><p>The <italic>cfr</italic> region in M12/0145 was also compared to the corresponding region in ST8-MRSA-IVa isolate M05/0060 carrying pSCFS7, the only previously described MRSA isolate recovered in Ireland found to carry <italic>cfr</italic> (<xref ref-type="fig" rid="F1">Fig. 1d</xref>). Although both <italic>cfr</italic> plasmids carried <italic>fexA</italic> and appeared to be derivatives of the insertion of IS<italic>21-558</italic> and <italic>cfr</italic> into Tn<italic>558</italic>, they differed mainly due to the insertion site of the IS element and <italic>cfr</italic> (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="fig" rid="F1">d</xref>). In pSCFS7, the integration of the IS<italic>21-558</italic>&#8211;<italic>cfr</italic> region within Tn<italic>558</italic> resulted in a truncation of the IS element and <italic>tnpB</italic>, while in M12/0145, both <italic>tnpA</italic> and <italic>tnpB</italic> are truncated, but the IS<italic>21-558</italic> element is intact (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="fig" rid="F1">d</xref>).</p><p>For isolate M13/0401, the <italic>cfr</italic>-carrying plasmid was 27,502 bp in size, and the region immediately upstream of <italic>cfr</italic> was similar to that in M12/0145 and consisted of <italic>orf2</italic> and IS<italic>21-558</italic> (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="fig" rid="F1">e</xref>). The DNA sequences of these genes were 100% identical to those found in M12/0145. The <italic>cfr</italic> gene differed by one nucleotide base only, at position 983, between the two isolates (T in M12/0145 and G in M13/0401), resulting in different amino acids in M12/0145 (serine) and M13/0401 (arginine). In contrast to the <italic>cfr</italic> region in M12/0145, the ABC transporter gene <italic>lsa</italic>(B), encoding low-level lincosamide resistance, was also detected upstream of <italic>cfr</italic> in M13/0401 (<xref ref-type="fig" rid="F1">Fig. 1e</xref>). This ABC transporter gene was previously detected in <italic>cfr</italic> plasmids p12-03322 (MRSE ST2) (<xref ref-type="fig" rid="F1">Fig. 1f</xref>) (<xref rid="B59" ref-type="bibr">59</xref>), pSCFS6 (<named-content content-type="genus-species">Staphylococcus warneri</named-content>) (<xref rid="B60" ref-type="bibr">60</xref>), and pSCFS1 (<named-content content-type="genus-species">Staphylococcus sciuri</named-content>) (<xref rid="B11" ref-type="bibr">11</xref>). However, the latter two plasmids (pSCFS6 and pSCFS1) differ substantially from the <italic>cfr</italic>-containing region identified in M13/0401, with pSCFS6 also containing <italic>fexA</italic> and pSCFS1 harboring the spectinomycin resistance gene <italic>spc</italic> and the macrolide-lincosamide-streptogramin B resistance gene <italic>erm</italic> (<xref rid="B33" ref-type="bibr">33</xref>) but lacking IS<italic>21-558</italic>. The genetic organization of the <italic>cfr</italic> region in M13/0401 showed the highest overall similarity to that of p12-00322 (<xref ref-type="fig" rid="F1">Fig. 1e</xref> and <xref ref-type="fig" rid="F1">f</xref>). However, in p12-00322, the <italic>cfr</italic> region is flanked by IS<italic>257</italic> elements, which were not identified in M13/0401. Similar to M12/0145, the region downstream of <italic>cfr</italic> in M13/0401 contained a transposase gene and an <italic>istB</italic>-like gene with 48% DNA sequence homology to <italic>istB</italic>, but these were not identified in p12-00322 (<xref ref-type="fig" rid="F1">Fig. 1e</xref> and <xref ref-type="fig" rid="F1">f</xref>).</p><p>The remainder of the <italic>cfr</italic>-carrying plasmid in M13/0401 was also distinct from p12-00322. While 14 additional ORFs were identified in the <italic>cfr</italic> plasmid in M13/0401, it lacked the putative conjugation machinery (<italic>tra</italic>), encompassing the majority of the remainder of p12-00322 (<xref rid="B59" ref-type="bibr">59</xref>). A gene (<italic>ssaA</italic>) encoding an SsaA-like transposon-related protein was detected 5,648 bp upstream of <italic>lsa</italic>(B) in M13/0401. The <italic>ssaA</italic> gene exhibited 63.3% DNA sequence homology to <italic>ssaA</italic> present on <named-content content-type="genus-species">Staphylococcus cohnii</named-content>
<italic>cfr</italic>-containing plasmid pHK01 (<xref rid="B61" ref-type="bibr">61</xref>) and 48.8% DNA sequence homology to <italic>ssaA</italic> on plasmids pSK73 (<named-content content-type="genus-species">S. aureus</named-content>) (GenBank accession no. <ext-link ext-link-type="gen" xlink:href="GQ915269.1">GQ915269.1</ext-link>) and p12-02300 (MRSE ST2) (<xref rid="B59" ref-type="bibr">59</xref>). A BLAST search of the amino acid sequences of other predicted ORFs identified within the DNA sequence of the <italic>cfr</italic>-carrying plasmid in M13/0401 indicated that although the percentage of homology was low (30 to 40%), a number of these proteins exhibited amino acid identity to proteins involved in DNA transfer, including a variety of proteins from bacilli and staphylococci involved in conjugation (see Table S3 in the supplemental material). The remaining predicted ORFs exhibited similarity to hypothetical proteins only.</p></sec><sec id="sec3-3"><title>Characterization of ribosomal mutations associated with linezolid resistance.</title><p>The same two mutations were detected in multiple 23S rRNA alleles and in L22 of both <italic>cfr</italic>-positive ST22-MRSA-IV isolates. These mutations included a change from guanine to thymine at nucleotide position 2603 (in 2/6 alleles in M12/0145 and in 1/5 alleles in M13/0401) in the V domain of the 23S rRNA gene and an amino acid change from alanine to valine at position 29 in L22. No amino acid changes were detected in the L3 or L4 proteins of either isolate.</p></sec></sec><sec sec-type="discussion" id="sec4"><title>DISCUSSION</title><p>The ST22-MRSA-IV clone is a pandemic nosocomial MRSA clone, and previous studies have revealed the ability of this clone to adapt to the introduction of different antimicrobial agents into the health care environment (<xref rid="B38" ref-type="bibr">38</xref>). In the present study, we report another step in the evolution of this MRSA clone, with the first report of the transferable multidrug resistance gene <italic>cfr</italic> in two independent ST22-MRSA-IV isolates. Although both isolates were from patients in Irish hospitals, they were epidemiologically unrelated, i.e., from two geographically disparate hospitals. In addition, although both isolates were assigned to <italic>spa</italic> type t032, and only a single difference was detected in their antimicrobial resistance phenotypes (rifampin resistance in one isolate only), DNA microarray profiling revealed some differences in terms of an additional antimicrobial resistance gene (<italic>fexA</italic>) and virulence gene complex (IEC) in one isolate. Whole-genome sequence analysis ultimately provided the definitive evidence that these two ST22-MRSA-IV isolates were genotypically as well as epidemiologically distinct, due to the large numbers of SNVs identified (603 SNVs).</p><p>Detailed plasmid analysis of the two ST22-MRSA-IV isolates revealed that <italic>cfr</italic> has been introduced on two distinct plasmids into ST22-MRSA-IV isolates. In MRSA ST22 isolate M12/0145, <italic>cfr</italic> and <italic>fexA</italic> were colocated on a conjugative plasmid that was very similar to pSA737 (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>), previously described in isolates of other MRSA genotypes and in a variety of coagulase-negative staphylococcal (CoNS) species from both animals and humans (see Table S3 in the supplemental material). Plasmid pSA737 is a pSCFS3-type plasmid, one of the most common types of <italic>cfr</italic>-containing plasmids. While the genetic environment of <italic>cfr</italic> in the second ST22-MRSA-IV isolate (M13/0401) revealed some similarities to that in M12/0145 in terms of the presence and location of <italic>orf2</italic> and the IS<italic>21-558</italic> transposase genes <italic>istAS</italic> and <italic>istBS</italic>, it was otherwise distinct from the plasmid in M12/0145. In fact, the <italic>cfr</italic> region in M13/0401 showed the most similarity to that in MRSE plasmid p12-00322, with both harboring <italic>lsa</italic>(B), but both <italic>cfr</italic> regions were carried on otherwise distinct plasmids. Genes with homology to those involved in mobility were identified in M13/0401, but the <italic>tra</italic> genes of p12-00322 were absent. Despite repeated attempts, filter-mating experiments using M13/0401 as a donor failed to yield any transconjugants, suggesting that the <italic>cfr</italic>-carrying plasmid present in M13/0401 was nonconjugative, at least under the conditions tested.</p><p>Anecdotal data on two additional linezolid-resistant ST22-MRSA-IV isolates recovered from two other patients in the same hospital as the one where M13/0401 was recovered, and within 3 months of the isolation of M13/0401, indicated that these two isolates were indistinguishable from M13/0401 based on antimicrobial susceptibility testing, <italic>spa</italic> typing, and DNA microarray data (data not shown). Although these two isolates were originally phenotypically linezolid resistant and <italic>cfr</italic> positive by PCR, they were subsequently found to be linezolid susceptible and to lack <italic>cfr</italic> following storage and subculturing, indicating the instability of the <italic>cfr</italic>-carrying plasmid in these isolates. However, the recovery of three genotypically indistinguishable <italic>cfr</italic>-positive isolates from patients in the same hospital in a similar time frame suggests the ability of this <italic>cfr</italic>-positive ST22-MRSA-IV strain to spread between patients. The patient from whom M12/0145 was recovered was also found to harbor an indistinguishable ST22-MRSA-IV strain based on DNA microarray profiling and <italic>spa</italic> typing that was linezolid susceptible and lacked <italic>cfr</italic> and the PhLOPS<sub>A</sub> phenotype (data not shown). Furthermore, the patient from whom M12/0145 was recovered had been treated previously with linezolid. This isolate may represent a precursor to the <italic>cfr</italic>-positive ST22-MRSA-IV isolate identified in the present study or an example of the loss of <italic>cfr</italic> in this strain.</p><p>The origin of the <italic>cfr</italic>-carrying plasmids in these ST22-MRSA-IV isolates is as yet unknown. Both plasmids were distinct from a previously reported <italic>cfr</italic>-carrying plasmid from a ST8-MRSA-IV isolate characterized in Ireland (<xref rid="B20" ref-type="bibr">20</xref>). The <italic>cfr</italic>-carrying plasmid in M12/0145 may have spread from other staphylococci, either <named-content content-type="genus-species">S. aureus</named-content> or CoNS, as the same plasmid types have been reported previously, in both human and animal staphylococcal isolates. The <italic>cfr</italic>-carrying plasmid from M13/0401 is distinct from those described previously, but similarities to those in MRSE suggest CoNS as a possible source. Recent reports of <italic>cfr</italic>-harboring MRSE isolates in Ireland raise the possibility that MRSE may be the source of these <italic>cfr</italic> plasmids, although analysis of the <italic>cfr</italic> region in these MRSE isolates has not yet been reported, so a comparison is not possible (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). Enterococci could also be the source of <italic>cfr</italic> in the ST22-MRSA-IV isolates, as linezolid resistance appears to be more common among enterococci. Only a single <italic>cfr</italic>-positive linezolid-resistant enterococcal isolate has been reported from Ireland, with no detailed plasmid analysis (<xref rid="B62" ref-type="bibr">62</xref>). Detailed systematic analysis of additional staphylococcal and enterococcal isolates from both animals and humans in Ireland for <italic>cfr</italic> is necessary to determine the source of these <italic>cfr</italic> plasmids and to prevent further spread.</p><p>Both <italic>cfr</italic>-positive ST22-MRSA-IV isolates also harbored a mutation in 23S rRNA (G2603T), and this mutation was shown previously to confer linezolid resistance in <named-content content-type="genus-species">S. aureus</named-content> and <named-content content-type="genus-species">S. epidermidis</named-content> (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B63" ref-type="bibr">63</xref>). Isolate M12/0145 exhibited a linezolid MIC of 64 mg/liter and harbored mutations in two 23S rRNA alleles, while isolate M13/0401 exhibited a linezolid MIC of 16 mg/liter and harbored mutations in one 23S rRNA allele, suggesting a possible relationship between the number of mutated alleles and the linezolid MIC. Furthermore, while curing both isolates of their <italic>cfr</italic>-carrying plasmids resulted in a reduction in their respective linezolid MICs, the cured derivative of M13/0401 was linezolid susceptible (linezolid MIC of 2 mg/liter), while that of M12/0145 (which had the two mutated 23S rRNA alleles) remained borderline linezolid resistant (linezolid MIC of 8 mg/liter). Mutations were also detected in the gene for the L22 protein, which resulted in the amino acid substitution A29V in both isolates. Little is known about the effects, if any, of L22 mutations on linezolid resistance, although it is assumed that L22 plays a role due to its close proximity to the linezolid binding site (<xref rid="B64" ref-type="bibr">64</xref>). The presence of distinct <italic>cfr</italic>-carrying plasmids in two ST22-MRSA-IV isolates indicates independent acquisition, and this, combined with mutation-mediated linezolid resistance, suggests that exposure to linezolid may have played a role in their emergence. Alternatively, since <italic>cfr</italic> encodes resistance to multiple antimicrobial agents, and because of the colocation of <italic>cfr</italic> on plasmids with other resistance genes in these isolates, i.e., <italic>fexA</italic> and <italic>lsa</italic>(B), other antimicrobial agents may provide the selective pressure for the emergence of <italic>cfr</italic>.</p><p>The identification of <italic>cfr</italic> in two distinct ST22-MRSA-IV strains is alarming. The distinct plasmids identified highlight the ability of <italic>cfr</italic> to spread and to complicate treatment options. Prudent management of linezolid usage is essential to prevent linezolid resistance from becoming more widespread.</p></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>Supplemental material</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_60_5_3007__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="AAC.02949-15_zac005165157so1.pdf"/>
</supplementary-material>
</sec>
</body><back><fn-group><fn fn-type="supplementary-material"><p>Supplemental material for this article may be found at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.02949-15">http://dx.doi.org/10.1128/AAC.02949-15</ext-link>.</p></fn></fn-group><ack><title>ACKNOWLEDGMENTS</title><p>We thank the staff of the National MRSA Reference Laboratory (NMRSARL) for technical assistance with antimicrobial susceptibility testing. <named-content content-type="genus-species">S. aureus</named-content> recipient strain XU21 was kindly provided by Edet Udo, Kuwait University. We thank Philip Murphy (Department of Clinical Microbiology, Trinity College Dublin, and The Adelaide and Meath Hospital incorporating the National Children's Hospital, Tallaght, Dublin) and Bartley Cryan (Cork University Hospital, Wilton, Cork, Ireland) for submitting the linezolid-resistant MRSA isolates investigated in the present study to the NMRSARL.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>DN</given-names></name>, <name><surname>Schluenzen</surname><given-names>F</given-names></name>, <name><surname>Harms</surname><given-names>JM</given-names></name>, <name><surname>Starosta</surname><given-names>AL</given-names></name>, <name><surname>Connell</surname><given-names>SR</given-names></name>, <name><surname>Fucini</surname><given-names>P</given-names></name></person-group>
<year>2008</year>
<article-title>The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>:<fpage>13339</fpage>&#8211;<lpage>13344</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0804276105</pub-id>.<pub-id pub-id-type="pmid">18757750</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolter</surname><given-names>N</given-names></name>, <name><surname>Smith</surname><given-names>AM</given-names></name>, <name><surname>Farrell</surname><given-names>DJ</given-names></name>, <name><surname>Schaffner</surname><given-names>W</given-names></name>, <name><surname>Moore</surname><given-names>M</given-names></name>, <name><surname>Whitney</surname><given-names>CG</given-names></name>, <name><surname>Jorgensen</surname><given-names>JH</given-names></name>, <name><surname>Klugman</surname><given-names>KP</given-names></name></person-group>
<year>2005</year>
<article-title>Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>49</volume>:<fpage>3554</fpage>&#8211;<lpage>3557</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.49.8.3554-3557.2005</pub-id>.<pub-id pub-id-type="pmid">16048983</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>KS</given-names></name>, <name><surname>Vester</surname><given-names>B</given-names></name></person-group>
<year>2012</year>
<article-title>Resistance to linezolid caused by modifications at its binding site on the ribosome</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>56</volume>:<fpage>603</fpage>&#8211;<lpage>612</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.05702-11</pub-id>.<pub-id pub-id-type="pmid">22143525</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrenberg</surname><given-names>C</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Jacobsen</surname><given-names>L</given-names></name>, <name><surname>Hansen</surname><given-names>LH</given-names></name>, <name><surname>Vester</surname><given-names>B</given-names></name></person-group>
<year>2005</year>
<article-title>A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503</article-title>. <source>Mol Microbiol</source>
<volume>57</volume>:<fpage>1064</fpage>&#8211;<lpage>1073</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04754.x</pub-id>.<pub-id pub-id-type="pmid">16091044</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giessing</surname><given-names>AM</given-names></name>, <name><surname>Jensen</surname><given-names>SS</given-names></name>, <name><surname>Rasmussen</surname><given-names>A</given-names></name>, <name><surname>Hansen</surname><given-names>LH</given-names></name>, <name><surname>Gondela</surname><given-names>A</given-names></name>, <name><surname>Long</surname><given-names>K</given-names></name>, <name><surname>Vester</surname><given-names>B</given-names></name>, <name><surname>Kirpekar</surname><given-names>F</given-names></name></person-group>
<year>2009</year>
<article-title>Identification of 8-methyladenosine as the modification catalyzed by the radical SAM methyltransferase Cfr that confers antibiotic resistance in bacteria</article-title>. <source>RNA</source>
<volume>15</volume>:<fpage>327</fpage>&#8211;<lpage>336</lpage>. doi:<pub-id pub-id-type="doi">10.1261/rna.1371409</pub-id>.<pub-id pub-id-type="pmid">19144912</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>KS</given-names></name>, <name><surname>Poehlsgaard</surname><given-names>J</given-names></name>, <name><surname>Kehrenberg</surname><given-names>C</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Vester</surname><given-names>B</given-names></name></person-group>
<year>2006</year>
<article-title>The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>50</volume>:<fpage>2500</fpage>&#8211;<lpage>2505</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00131-06</pub-id>.<pub-id pub-id-type="pmid">16801432</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Lv</surname><given-names>Y</given-names></name>, <name><surname>Cai</surname><given-names>J</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Cui</surname><given-names>L</given-names></name>, <name><surname>Hu</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>R</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>Q</given-names></name>, <name><surname>He</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Shen</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Fe&#223;ler</surname><given-names>AT</given-names></name>, <name><surname>Wu</surname><given-names>C</given-names></name>, <name><surname>Yu</surname><given-names>H</given-names></name>, <name><surname>Deng</surname><given-names>X</given-names></name>, <name><surname>Xia</surname><given-names>X</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name></person-group>
<year>2015</year>
<article-title>A novel gene, <italic>optrA</italic>, that confers transferable resistance to oxazolidinones and phenicols and its presence in <named-content content-type="genus-species">Enterococcus faecalis</named-content> and <named-content content-type="genus-species">Enterococcus faecium</named-content> of human and animal origin</article-title>. <source>J Antimicrob Chemother</source>
<volume>70</volume>:<fpage>2182</fpage>&#8211;<lpage>2190</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkv116</pub-id>.<pub-id pub-id-type="pmid">25977397</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>LM</given-names></name>, <name><surname>Ashcraft</surname><given-names>DS</given-names></name>, <name><surname>Kahn</surname><given-names>HP</given-names></name>, <name><surname>Pankey</surname><given-names>G</given-names></name>, <name><surname>Jones</surname><given-names>RN</given-names></name>, <name><surname>Farrell</surname><given-names>DJ</given-names></name>, <name><surname>Mendes</surname><given-names>RE</given-names></name></person-group>
<year>2015</year>
<article-title>Detection of a new <italic>cfr</italic>-like gene, <italic>cfr</italic>(B), in <italic>Enterococcus faecium</italic> isolates recovered from human specimens in the United States as part of the SENTRY antimicrobial surveillance program</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>59</volume>:<fpage>6256</fpage>&#8211;<lpage>6261</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01473-15</pub-id>.<pub-id pub-id-type="pmid">26248384</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>LH</given-names></name>, <name><surname>Vester</surname><given-names>B</given-names></name></person-group>
<year>2015</year>
<article-title>A <italic>cfr</italic>-like gene from <named-content content-type="genus-species">Clostridium difficile</named-content> confers multiple antibiotic resistance by the same mechanism as the <italic>cfr</italic> gene</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>59</volume>:<fpage>5841</fpage>&#8211;<lpage>5843</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01274-15</pub-id>.<pub-id pub-id-type="pmid">26149991</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name></person-group>
<year>2013</year>
<article-title>Presence and dissemination of the multiresistance gene <italic>cfr</italic> in Gram-positive and Gram-negative bacteria</article-title>. <source>J Antimicrob Chemother</source>
<volume>68</volume>:<fpage>1697</fpage>&#8211;<lpage>1706</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkt092</pub-id>.<pub-id pub-id-type="pmid">23543608</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Werckenthin</surname><given-names>C</given-names></name>, <name><surname>Kehrenberg</surname><given-names>C</given-names></name></person-group>
<year>2000</year>
<article-title>Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in <named-content content-type="genus-species">Staphylococcus sciuri</named-content></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>44</volume>:<fpage>2530</fpage>&#8211;<lpage>2533</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.44.9.2530-2533.2000</pub-id>.<pub-id pub-id-type="pmid">10952608</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>D</given-names></name>, <name><surname>Song</surname><given-names>L</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>He</surname><given-names>T</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <name><surname>Wu</surname><given-names>C</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name></person-group>
<year>2013</year>
<article-title>First report of the multiresistance gene <italic>cfr</italic> in <named-content content-type="genus-species">Streptococcus suis</named-content></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>57</volume>:<fpage>4061</fpage>&#8211;<lpage>4063</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00713-13</pub-id>.<pub-id pub-id-type="pmid">23733472</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>ZL</given-names></name>, <name><surname>Wei</surname><given-names>HK</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Lin</surname><given-names>DC</given-names></name>, <name><surname>Liu</surname><given-names>XQ</given-names></name>, <name><surname>Liu</surname><given-names>JH</given-names></name></person-group>
<year>2014</year>
<article-title>High prevalence of Cfr-producing <named-content content-type="genus-species">Staphylococcus</named-content> species in retail meat in Guangzhou, China</article-title>. <source>BMC Microbiol</source>
<volume>14</volume>:<fpage>151</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2180-14-151</pub-id>.<pub-id pub-id-type="pmid">24913069</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>RE</given-names></name>, <name><surname>Hogan</surname><given-names>PA</given-names></name>, <name><surname>Streit</surname><given-names>JM</given-names></name>, <name><surname>Jones</surname><given-names>RN</given-names></name>, <name><surname>Flamm</surname><given-names>RK</given-names></name></person-group>
<year>2014</year>
<article-title>Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12)</article-title>. <source>J Antimicrob Chemother</source>
<volume>69</volume>:<fpage>1582</fpage>&#8211;<lpage>1588</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkt541</pub-id>.<pub-id pub-id-type="pmid">24468866</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>B</given-names></name>, <name><surname>Kelesidis</surname><given-names>T</given-names></name>, <name><surname>Tsiodras</surname><given-names>S</given-names></name>, <name><surname>Hindler</surname><given-names>J</given-names></name>, <name><surname>Humphries</surname><given-names>RM</given-names></name></person-group>
<year>2013</year>
<article-title>The emerging problem of linezolid-resistant <named-content content-type="genus-species">Staphylococcus</named-content></article-title>. <source>J Antimicrob Chemother</source>
<volume>68</volume>:<fpage>4</fpage>&#8211;<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dks354</pub-id>.<pub-id pub-id-type="pmid">22949625</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flamm</surname><given-names>RK</given-names></name>, <name><surname>Mendes</surname><given-names>RE</given-names></name>, <name><surname>Hogan</surname><given-names>PA</given-names></name>, <name><surname>Ross</surname><given-names>JE</given-names></name>, <name><surname>Farrell</surname><given-names>DJ</given-names></name>, <name><surname>Jones</surname><given-names>RN</given-names></name></person-group>
<year>2015</year>
<article-title>In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program</article-title>. <source>Diagn Microbiol Infect Dis</source>
<volume>81</volume>:<fpage>283</fpage>&#8211;<lpage>289</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2014.12.009</pub-id>.<pub-id pub-id-type="pmid">25633420</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>JB</given-names></name>, <name><surname>Zuill</surname><given-names>DE</given-names></name>, <name><surname>Scharn</surname><given-names>CR</given-names></name>, <name><surname>Deane</surname><given-names>J</given-names></name>, <name><surname>Sahm</surname><given-names>DF</given-names></name>, <name><surname>Denys</surname><given-names>GA</given-names></name>, <name><surname>Goering</surname><given-names>RV</given-names></name>, <name><surname>Shaw</surname><given-names>KJ</given-names></name></person-group>
<year>2014</year>
<article-title>Linezolid-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> strain 1128105, the first known clinical isolate possessing the <italic>cfr</italic> multidrug resistance gene</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>58</volume>:<fpage>6592</fpage>&#8211;<lpage>6598</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.03493-14</pub-id>.<pub-id pub-id-type="pmid">25155597</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>JB</given-names></name>, <name><surname>Rahawi</surname><given-names>S</given-names></name>, <name><surname>Lamarre</surname><given-names>J</given-names></name>, <name><surname>Mankin</surname><given-names>AS</given-names></name>, <name><surname>Shaw</surname><given-names>KJ</given-names></name></person-group>
<year>2012</year>
<article-title>Genetic environment and stability of <italic>cfr</italic> in methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> CM05</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>56</volume>:<fpage>332</fpage>&#8211;<lpage>340</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.05420-11</pub-id>.<pub-id pub-id-type="pmid">22024827</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>JB</given-names></name>, <name><surname>Zuill</surname><given-names>DE</given-names></name>, <name><surname>Scharn</surname><given-names>CR</given-names></name>, <name><surname>Deane</surname><given-names>J</given-names></name>, <name><surname>Sahm</surname><given-names>DF</given-names></name>, <name><surname>Goering</surname><given-names>RV</given-names></name>, <name><surname>Jenkins</surname><given-names>SG</given-names></name>, <name><surname>Shaw</surname><given-names>KJ</given-names></name></person-group>
<year>2014</year>
<article-title>Identification and characterization of linezolid-resistant <italic>cfr</italic>-positive <named-content content-type="genus-species">Staphylococcus aureus</named-content> USA300 isolates from a New York City medical center</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>58</volume>:<fpage>6949</fpage>&#8211;<lpage>6952</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.03380-14</pub-id>.<pub-id pub-id-type="pmid">25136008</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shore</surname><given-names>AC</given-names></name>, <name><surname>Brennan</surname><given-names>OM</given-names></name>, <name><surname>Ehricht</surname><given-names>R</given-names></name>, <name><surname>Monecke</surname><given-names>S</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Slickers</surname><given-names>P</given-names></name>, <name><surname>Coleman</surname><given-names>DC</given-names></name></person-group>
<year>2010</year>
<article-title>Identification and characterization of the multidrug resistance gene <italic>cfr</italic> in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> IVa (USA300) isolate</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>54</volume>:<fpage>4978</fpage>&#8211;<lpage>4984</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01113-10</pub-id>.<pub-id pub-id-type="pmid">20921317</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrenberg</surname><given-names>C</given-names></name>, <name><surname>Cuny</surname><given-names>C</given-names></name>, <name><surname>Strommenger</surname><given-names>B</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Witte</surname><given-names>W</given-names></name></person-group>
<year>2009</year>
<article-title>Methicillin-resistant and -susceptible <named-content content-type="genus-species">Staphylococcus aureus</named-content> strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene <italic>cfr</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>53</volume>:<fpage>779</fpage>&#8211;<lpage>781</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01376-08</pub-id>.<pub-id pub-id-type="pmid">19047652</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fe&#223;ler</surname><given-names>AT</given-names></name>, <name><surname>Calvo</surname><given-names>N</given-names></name>, <name><surname>Gutierrez</surname><given-names>N</given-names></name>, <name><surname>Munoz Bellido</surname><given-names>JL</given-names></name>, <name><surname>Fajardo</surname><given-names>M</given-names></name>, <name><surname>Garduno</surname><given-names>E</given-names></name>, <name><surname>Monecke</surname><given-names>S</given-names></name>, <name><surname>Ehricht</surname><given-names>R</given-names></name>, <name><surname>Kadlec</surname><given-names>K</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name></person-group>
<year>2014</year>
<article-title>Cfr-mediated linezolid resistance in methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> and <named-content content-type="genus-species">Staphylococcus haemolyticus</named-content> associated with clinical infections in humans: two case reports</article-title>. <source>J Antimicrob Chemother</source>
<volume>69</volume>:<fpage>268</fpage>&#8211;<lpage>270</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkt331</pub-id>.<pub-id pub-id-type="pmid">23960042</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name>, <name><surname>Wu</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Fan</surname><given-names>R</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title>Identification of multiresistance gene <italic>cfr</italic> in methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> from pigs: plasmid location and integration into a staphylococcal cassette chromosome <italic>mec</italic> complex</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>59</volume>:<fpage>3641</fpage>&#8211;<lpage>3644</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00500-15</pub-id>.<pub-id pub-id-type="pmid">25824234</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>JC</given-names></name>, <name><surname>Hu</surname><given-names>YY</given-names></name>, <name><surname>Zhou</surname><given-names>HW</given-names></name>, <name><surname>Chen</surname><given-names>GX</given-names></name>, <name><surname>Zhang</surname><given-names>R</given-names></name></person-group>
<year>2015</year>
<article-title>Dissemination of the same <italic>cfr</italic>-carrying plasmid among methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> and coagulase-negative staphylococcal isolates in China</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>59</volume>:<fpage>3669</fpage>&#8211;<lpage>3671</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.04580-14</pub-id>.<pub-id pub-id-type="pmid">25870066</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>W</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>C</given-names></name>, <name><surname>Shen</surname><given-names>Z</given-names></name>, <name><surname>Fu</surname><given-names>X</given-names></name>, <name><surname>Yan</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name></person-group>
<year>2012</year>
<article-title>Distribution of the multidrug resistance gene <italic>cfr</italic> in <named-content content-type="genus-species">Staphylococcus</named-content> species isolates from swine farms in China</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>56</volume>:<fpage>1485</fpage>&#8211;<lpage>1490</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.05827-11</pub-id>.<pub-id pub-id-type="pmid">22183168</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>JM</given-names></name>, <name><surname>Camoez</surname><given-names>M</given-names></name>, <name><surname>Tubau</surname><given-names>F</given-names></name>, <name><surname>Gasch</surname><given-names>O</given-names></name>, <name><surname>Pujol</surname><given-names>M</given-names></name>, <name><surname>Martin</surname><given-names>R</given-names></name>, <name><surname>Dominguez</surname><given-names>MA</given-names></name></person-group>
<year>2013</year>
<article-title>Low prevalence of Cfr-mediated linezolid resistance among methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> in a Spanish hospital: case report on linezolid resistance acquired during linezolid therapy</article-title>. <source>PLoS One</source>
<volume>8</volume>:<fpage>e59215</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0059215</pub-id>.<pub-id pub-id-type="pmid">23554998</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopegui</surname><given-names>ER</given-names></name>, <name><surname>Juan</surname><given-names>C</given-names></name>, <name><surname>Zamorano</surname><given-names>L</given-names></name>, <name><surname>Perez</surname><given-names>JL</given-names></name>, <name><surname>Oliver</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>Transferable multidrug resistance plasmid carrying <italic>cfr</italic> associated with <italic>tet</italic>(L), <italic>ant(4&#8242;)-Ia</italic>, and <italic>dfrK</italic> genes from a clinical methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> ST125 strain</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>56</volume>:<fpage>2139</fpage>&#8211;<lpage>2142</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.06042-11</pub-id>.<pub-id pub-id-type="pmid">22214776</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>G</given-names></name>, <name><surname>Picazo</surname><given-names>JJ</given-names></name>, <name><surname>Baos</surname><given-names>E</given-names></name>, <name><surname>Candel</surname><given-names>FJ</given-names></name>, <name><surname>Arribi</surname><given-names>A</given-names></name>, <name><surname>Pelaez</surname><given-names>B</given-names></name>, <name><surname>Andrade</surname><given-names>R</given-names></name>, <name><surname>de la Torre</surname><given-names>MA</given-names></name>, <name><surname>Fereres</surname><given-names>J</given-names></name>, <name><surname>Sanchez-Garcia</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>Resistance to linezolid is mediated by the <italic>cfr</italic> gene in the first report of an outbreak of linezolid-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content></article-title>. <source>Clin Infect Dis</source>
<volume>50</volume>:<fpage>821</fpage>&#8211;<lpage>825</lpage>. doi:<pub-id pub-id-type="doi">10.1086/650574</pub-id>.<pub-id pub-id-type="pmid">20144045</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>RE</given-names></name>, <name><surname>Deshpande</surname><given-names>LM</given-names></name>, <name><surname>Castanheira</surname><given-names>M</given-names></name>, <name><surname>DiPersio</surname><given-names>J</given-names></name>, <name><surname>Saubolle</surname><given-names>MA</given-names></name>, <name><surname>Jones</surname><given-names>RN</given-names></name></person-group>
<year>2008</year>
<article-title>First report of <italic>cfr</italic>-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>52</volume>:<fpage>2244</fpage>&#8211;<lpage>2246</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00231-08</pub-id>.<pub-id pub-id-type="pmid">18391032</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>RE</given-names></name>, <name><surname>Deshpande</surname><given-names>LM</given-names></name>, <name><surname>Bonilla</surname><given-names>HF</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Huband</surname><given-names>MD</given-names></name>, <name><surname>Jones</surname><given-names>RN</given-names></name>, <name><surname>Quinn</surname><given-names>JP</given-names></name></person-group>
<year>2013</year>
<article-title>Dissemination of a pSCFS3-like <italic>cfr</italic>-carrying plasmid in <named-content content-type="genus-species">Staphylococcus aureus</named-content> and <named-content content-type="genus-species">Staphylococcus epidermidis</named-content> clinical isolates recovered from hospitals in Ohio</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>57</volume>:<fpage>2923</fpage>&#8211;<lpage>2928</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00071-13</pub-id>.<pub-id pub-id-type="pmid">23571552</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gales</surname><given-names>AC</given-names></name>, <name><surname>Deshpande</surname><given-names>LM</given-names></name>, <name><surname>de Souza</surname><given-names>AG</given-names></name>, <name><surname>Pignatari</surname><given-names>AC</given-names></name>, <name><surname>Mendes</surname><given-names>RE</given-names></name></person-group>
<year>2015</year>
<article-title>MSSA ST398/t034 carrying a plasmid-mediated Cfr and Erm(B) in Brazil</article-title>. <source>J Antimicrob Chemother</source>
<volume>70</volume>:<fpage>303</fpage>&#8211;<lpage>305</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dku366</pub-id>.<pub-id pub-id-type="pmid">25261421</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endimiani</surname><given-names>A</given-names></name>, <name><surname>Blackford</surname><given-names>M</given-names></name>, <name><surname>Dasenbrook</surname><given-names>EC</given-names></name>, <name><surname>Reed</surname><given-names>MD</given-names></name>, <name><surname>Bajaksouszian</surname><given-names>S</given-names></name>, <name><surname>Hujer</surname><given-names>AM</given-names></name>, <name><surname>Rudin</surname><given-names>SD</given-names></name>, <name><surname>Hujer</surname><given-names>KM</given-names></name>, <name><surname>Perreten</surname><given-names>V</given-names></name>, <name><surname>Rice</surname><given-names>LB</given-names></name>, <name><surname>Jacobs</surname><given-names>MR</given-names></name>, <name><surname>Konstan</surname><given-names>MW</given-names></name>, <name><surname>Bonomo</surname><given-names>RA</given-names></name></person-group>
<year>2011</year>
<article-title>Emergence of linezolid-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>55</volume>:<fpage>1684</fpage>&#8211;<lpage>1692</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01308-10</pub-id>.<pub-id pub-id-type="pmid">21263048</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toh</surname><given-names>SM</given-names></name>, <name><surname>Xiong</surname><given-names>L</given-names></name>, <name><surname>Arias</surname><given-names>CA</given-names></name>, <name><surname>Villegas</surname><given-names>MV</given-names></name>, <name><surname>Lolans</surname><given-names>K</given-names></name>, <name><surname>Quinn</surname><given-names>J</given-names></name>, <name><surname>Mankin</surname><given-names>AS</given-names></name></person-group>
<year>2007</year>
<article-title>Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> resistant to the synthetic antibiotic linezolid</article-title>. <source>Mol Microbiol</source>
<volume>64</volume>:<fpage>1506</fpage>&#8211;<lpage>1514</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.05744.x</pub-id>.<pub-id pub-id-type="pmid">17555436</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabriel</surname><given-names>EM</given-names></name>, <name><surname>Fitzgibbon</surname><given-names>S</given-names></name>, <name><surname>Clair</surname><given-names>J</given-names></name>, <name><surname>Coffey</surname><given-names>A</given-names></name>, <name><surname>O'Mahony</surname><given-names>JM</given-names></name></person-group>
<year>2015</year>
<article-title>Characterisation of clinical meticillin-resistant <named-content content-type="genus-species">Staphylococcus epidermidis</named-content> demonstrating high levels of linezolid resistance (&gt;256 &#181;g/ml) resulting from transmissible and mutational mechanisms</article-title>. <source>J Infect Chemother</source>
<volume>21</volume>:<fpage>547</fpage>&#8211;<lpage>549</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jiac.2015.03.012</pub-id>.<pub-id pub-id-type="pmid">25913534</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname><given-names>C</given-names></name>, <name><surname>Powell</surname><given-names>J</given-names></name>, <name><surname>Finnegan</surname><given-names>C</given-names></name>, <name><surname>O'Gorman</surname><given-names>A</given-names></name>, <name><surname>Barrett</surname><given-names>S</given-names></name>, <name><surname>Hopkins</surname><given-names>KL</given-names></name>, <name><surname>Pichon</surname><given-names>B</given-names></name>, <name><surname>Hill</surname><given-names>R</given-names></name>, <name><surname>Power</surname><given-names>L</given-names></name>, <name><surname>Woodford</surname><given-names>N</given-names></name>, <name><surname>Coffey</surname><given-names>JC</given-names></name>, <name><surname>Kearns</surname><given-names>A</given-names></name>, <name><surname>O'Connell</surname><given-names>NH</given-names></name>, <name><surname>Dunne</surname><given-names>CP</given-names></name></person-group>
<year>2015</year>
<article-title>Incidence, management and outcomes of the first <italic>cfr</italic>-mediated linezolid-resistant <named-content content-type="genus-species">Staphylococcus epidermidis</named-content> outbreak in a tertiary referral centre in the Republic of Ireland</article-title>. <source>J Hosp Infect</source>
<volume>90</volume>:<fpage>316</fpage>&#8211;<lpage>321</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jhin.2014.12.013</pub-id>.<pub-id pub-id-type="pmid">25648941</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shore</surname><given-names>AC</given-names></name>, <name><surname>Rossney</surname><given-names>AS</given-names></name>, <name><surname>Kinnevey</surname><given-names>PM</given-names></name>, <name><surname>Brennan</surname><given-names>OM</given-names></name>, <name><surname>Creamer</surname><given-names>E</given-names></name>, <name><surname>Sherlock</surname><given-names>O</given-names></name>, <name><surname>Dolan</surname><given-names>A</given-names></name>, <name><surname>Cunney</surname><given-names>R</given-names></name>, <name><surname>Sullivan</surname><given-names>DJ</given-names></name>, <name><surname>Goering</surname><given-names>RV</given-names></name>, <name><surname>Humphreys</surname><given-names>H</given-names></name>, <name><surname>Coleman</surname><given-names>DC</given-names></name></person-group>
<year>2010</year>
<article-title>Enhanced discrimination of highly clonal ST22-methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> IV isolates achieved by combining <italic>spa</italic>, <italic>dru</italic>, and pulsed-field gel electrophoresis typing data</article-title>. <source>J Clin Microbiol</source>
<volume>48</volume>:<fpage>1839</fpage>&#8211;<lpage>1852</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.02155-09</pub-id>.<pub-id pub-id-type="pmid">20335411</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundmann</surname><given-names>H</given-names></name>, <name><surname>Schouls</surname><given-names>LM</given-names></name>, <name><surname>Aanensen</surname><given-names>DM</given-names></name>, <name><surname>Pluister</surname><given-names>GN</given-names></name>, <name><surname>Tami</surname><given-names>A</given-names></name>, <name><surname>Chlebowicz</surname><given-names>M</given-names></name>, <name><surname>Glasner</surname><given-names>C</given-names></name>, <name><surname>Sabat</surname><given-names>AJ</given-names></name>, <name><surname>Weist</surname><given-names>K</given-names></name>, <name><surname>Heuer</surname><given-names>O</given-names></name>, <name><surname>Friedrich</surname><given-names>AW</given-names></name></person-group>, <collab>ESCMID Study Group on Molecular Epidemiological Markers, European Staphylococcal Reference Laboratory Working Group</collab>. <year>2014</year>
<article-title>The dynamic changes of dominant clones of <named-content content-type="genus-species">Staphylococcus aureus</named-content> causing bloodstream infections in the European region: results of a second structured survey</article-title>. <source>Euro Surveill</source>
<volume>19</volume>(<issue>49</issue>):<fpage>pii=20987</fpage>
<comment><ext-link ext-link-type="uri" xlink:href="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20987">http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20987</ext-link></comment>.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holden</surname><given-names>MT</given-names></name>, <name><surname>Hsu</surname><given-names>LY</given-names></name>, <name><surname>Kurt</surname><given-names>K</given-names></name>, <name><surname>Weinert</surname><given-names>LA</given-names></name>, <name><surname>Mather</surname><given-names>AE</given-names></name>, <name><surname>Harris</surname><given-names>SR</given-names></name>, <name><surname>Strommenger</surname><given-names>B</given-names></name>, <name><surname>Layer</surname><given-names>F</given-names></name>, <name><surname>Witte</surname><given-names>W</given-names></name>, <name><surname>de Lencastre</surname><given-names>H</given-names></name>, <name><surname>Skov</surname><given-names>R</given-names></name>, <name><surname>Westh</surname><given-names>H</given-names></name>, <name><surname>Zemlickova</surname><given-names>H</given-names></name>, <name><surname>Coombs</surname><given-names>G</given-names></name>, <name><surname>Kearns</surname><given-names>AM</given-names></name>, <name><surname>Hill</surname><given-names>RL</given-names></name>, <name><surname>Edgeworth</surname><given-names>J</given-names></name>, <name><surname>Gould</surname><given-names>I</given-names></name>, <name><surname>Gant</surname><given-names>V</given-names></name>, <name><surname>Cooke</surname><given-names>J</given-names></name>, <name><surname>Edwards</surname><given-names>GF</given-names></name>, <name><surname>McAdam</surname><given-names>PR</given-names></name>, <name><surname>Templeton</surname><given-names>KE</given-names></name>, <name><surname>McCann</surname><given-names>A</given-names></name>, <name><surname>Zhou</surname><given-names>Z</given-names></name>, <name><surname>Castillo-Ramirez</surname><given-names>S</given-names></name>, <name><surname>Feil</surname><given-names>EJ</given-names></name>, <name><surname>Hudson</surname><given-names>LO</given-names></name>, <name><surname>Enright</surname><given-names>MC</given-names></name>, <name><surname>Balloux</surname><given-names>F</given-names></name>, <name><surname>Aanensen</surname><given-names>DM</given-names></name>, <name><surname>Spratt</surname><given-names>BG</given-names></name>, <name><surname>Fitzgerald</surname><given-names>JR</given-names></name>, <name><surname>Parkhill</surname><given-names>J</given-names></name>, <name><surname>Achtman</surname><given-names>M</given-names></name>, <name><surname>Bentley</surname><given-names>SD</given-names></name>, <name><surname>Nubel</surname><given-names>U</given-names></name></person-group>
<year>2013</year>
<article-title>A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> pandemic</article-title>. <source>Genome Res</source>
<volume>23</volume>:<fpage>653</fpage>&#8211;<lpage>664</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.147710.112</pub-id>.<pub-id pub-id-type="pmid">23299977</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>KT</given-names></name>, <name><surname>Hanifah</surname><given-names>YA</given-names></name>, <name><surname>Yusof</surname><given-names>MY</given-names></name>, <name><surname>Goering</surname><given-names>RV</given-names></name>, <name><surname>Thong</surname><given-names>KL</given-names></name></person-group>
<year>2012</year>
<article-title>Temporal changes in the genotypes of methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> strains isolated from a tertiary Malaysian hospital based on MLST, <italic>spa</italic>, and <italic>mec</italic>-associated <italic>dru</italic> typing</article-title>. <source>Diagn Microbiol Infect Dis</source>
<volume>74</volume>:<fpage>106</fpage>&#8211;<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2012.05.033</pub-id>.<pub-id pub-id-type="pmid">22770652</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coombs</surname><given-names>GW</given-names></name>, <name><surname>Nimmo</surname><given-names>GR</given-names></name>, <name><surname>Daly</surname><given-names>DA</given-names></name>, <name><surname>Le</surname><given-names>TT</given-names></name>, <name><surname>Pearson</surname><given-names>JC</given-names></name>, <name><surname>Tan</surname><given-names>HL</given-names></name>, <name><surname>Robinson</surname><given-names>JO</given-names></name>, <name><surname>Collignon</surname><given-names>PJ</given-names></name>, <name><surname>McLaws</surname><given-names>ML</given-names></name>, <name><surname>Turnidge</surname><given-names>JD</given-names></name></person-group>, <collab>Australian Group on Antimicrobial Resistance</collab>. <year>2014</year>
<article-title>Australian <named-content content-type="genus-species">Staphylococcus aureus</named-content> Sepsis Outcome Programme annual report, 2013</article-title>. <source>Commun Dis Intell Q Rep</source>
<volume>38</volume>:<fpage>E309</fpage>&#8211;<lpage>E319</lpage>.<pub-id pub-id-type="pmid">25631593</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teo</surname><given-names>J</given-names></name>, <name><surname>Tan</surname><given-names>TY</given-names></name>, <name><surname>Hon</surname><given-names>PY</given-names></name>, <name><surname>Lee</surname><given-names>W</given-names></name>, <name><surname>Koh</surname><given-names>TH</given-names></name>, <name><surname>Krishnan</surname><given-names>P</given-names></name>, <name><surname>Hsu</surname><given-names>LY</given-names></name></person-group>, <collab>Network for Antimicrobial Resistance Surveillance (Singapore)</collab>. <year>2013</year>
<article-title>ST22 and ST239 MRSA duopoly in Singaporean hospitals: 2006-2010</article-title>. <source>Epidemiol Infect</source>
<volume>141</volume>:<fpage>153</fpage>&#8211;<lpage>157</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0950268812000337</pub-id>.<pub-id pub-id-type="pmid">22394568</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenover</surname><given-names>FC</given-names></name>, <name><surname>Tickler</surname><given-names>IA</given-names></name>, <name><surname>Goering</surname><given-names>RV</given-names></name>, <name><surname>Kreiswirth</surname><given-names>BN</given-names></name>, <name><surname>Mediavilla</surname><given-names>JR</given-names></name>, <name><surname>Persing</surname><given-names>DH</given-names></name></person-group>, <collab>MRSA Consortium</collab>. <year>2012</year>
<article-title>Characterization of nasal and blood culture isolates of methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> from patients in United States hospitals</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>56</volume>:<fpage>1324</fpage>&#8211;<lpage>1330</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.05804-11</pub-id>.<pub-id pub-id-type="pmid">22155818</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caboclo</surname><given-names>RM</given-names></name>, <name><surname>Cavalcante</surname><given-names>FS</given-names></name>, <name><surname>Iorio</surname><given-names>NL</given-names></name>, <name><surname>Schuenck</surname><given-names>RP</given-names></name>, <name><surname>Olendzki</surname><given-names>AN</given-names></name>, <name><surname>Felix</surname><given-names>MJ</given-names></name>, <name><surname>Chamon</surname><given-names>RC</given-names></name>, <name><surname>dos Santos</surname><given-names>KR</given-names></name></person-group>
<year>2013</year>
<article-title>Methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> in Rio de Janeiro hospitals: dissemination of the USA400/ST1 and USA800/ST5 SCC<italic>mec</italic> type IV and USA100/ST5 SCC<italic>mec</italic> type II lineages in a public institution and polyclonal presence in a private one</article-title>. <source>Am J Infect Control</source>
<volume>41</volume>:<fpage>e21</fpage>&#8211;<lpage>e26</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajic.2012.08.008</pub-id>.<pub-id pub-id-type="pmid">23261682</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witte</surname><given-names>W</given-names></name>, <name><surname>Cuny</surname><given-names>C</given-names></name></person-group>
<year>2011</year>
<article-title>Emergence and spread of <italic>cfr</italic>-mediated multiresistance in staphylococci: an interdisciplinary challenge</article-title>. <source>Future Microbiol</source>
<volume>6</volume>:<fpage>925</fpage>&#8211;<lpage>931</lpage>. doi:<pub-id pub-id-type="doi">10.2217/fmb.11.69</pub-id>.<pub-id pub-id-type="pmid">21861622</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossney</surname><given-names>AS</given-names></name>, <name><surname>English</surname><given-names>LF</given-names></name>, <name><surname>Keane</surname><given-names>CT</given-names></name></person-group>
<year>1990</year>
<article-title>Coagulase testing compared with commercial kits for routinely identifying <named-content content-type="genus-species">Staphylococcus aureus</named-content></article-title>. <source>J Clin Pathol</source>
<volume>43</volume>:<fpage>246</fpage>&#8211;<lpage>252</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jcp.43.3.246</pub-id>.<pub-id pub-id-type="pmid">2185284</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="web"><collab>European Committee on Antimicrobial Susceptibility Testing</collab>. <year>2014</year>
<article-title>Breakpoint tables for interpretation of MICs and zone diameters, version 4.0</article-title>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.eucast.org/clinical_breakpoints/">http://www.eucast.org/clinical_breakpoints/</ext-link></comment>.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="web"><collab>European Committee on Antimicrobial Susceptibility Testing</collab>. <year>2015</year>
<article-title>Antimicrobial susceptibility testing</article-title>. <source>EUCAST disk diffusion method, version 5.0</source>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.eucast.org/ast_of_bacteria/disk_diffusion_methodology/">http://www.eucast.org/ast_of_bacteria/disk_diffusion_methodology/</ext-link></comment>.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udo</surname><given-names>EE</given-names></name>, <name><surname>Jacob</surname><given-names>LE</given-names></name>, <name><surname>Mokadas</surname><given-names>EM</given-names></name></person-group>
<year>1997</year>
<article-title>Conjugative transfer of high-level mupirocin resistance from <named-content content-type="genus-species">Staphylococcus haemolyticus</named-content> to other staphylococci</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>41</volume>:<fpage>693</fpage>&#8211;<lpage>695</lpage>.<pub-id pub-id-type="pmid">9056015</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="book"><collab>Clinical and Laboratory Standards Institute</collab>. <year>2006</year>
<article-title>Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically; approved standard</article-title>, <edition>7th ed</edition>
<source>CLSI document M7-A7</source>. <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>, <publisher-loc>Wayne, PA</publisher-loc>.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McManus</surname><given-names>BA</given-names></name>, <name><surname>Coleman</surname><given-names>DC</given-names></name>, <name><surname>Deasy</surname><given-names>EC</given-names></name>, <name><surname>Brennan</surname><given-names>GI</given-names></name>, <name><surname>O'Connell</surname><given-names>B</given-names></name>, <name><surname>Monecke</surname><given-names>S</given-names></name>, <name><surname>Ehricht</surname><given-names>R</given-names></name>, <name><surname>Leggett</surname><given-names>B</given-names></name>, <name><surname>Leonard</surname><given-names>N</given-names></name>, <name><surname>Shore</surname><given-names>AC</given-names></name></person-group>
<year>2015</year>
<article-title>Comparative genotypes, staphylococcal cassette chromosome <italic>mec</italic> (SCC<italic>mec</italic>) genes and antimicrobial resistance amongst <named-content content-type="genus-species">Staphylococcus epidermidis</named-content> and <named-content content-type="genus-species">Staphylococcus haemolyticus</named-content> isolates from infections in humans and companion animals</article-title>. <source>PLoS One</source>
<volume>10</volume>:<fpage>e0138079</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0138079</pub-id>.<pub-id pub-id-type="pmid">26379051</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellmann</surname><given-names>A</given-names></name>, <name><surname>Weniger</surname><given-names>T</given-names></name>, <name><surname>Berssenbrugge</surname><given-names>C</given-names></name>, <name><surname>Rothganger</surname><given-names>J</given-names></name>, <name><surname>Sammeth</surname><given-names>M</given-names></name>, <name><surname>Stoye</surname><given-names>J</given-names></name>, <name><surname>Harmsen</surname><given-names>D</given-names></name></person-group>
<year>2007</year>
<article-title>Based Upon Repeat Pattern (BURP): an algorithm to characterize the long-term evolution of <named-content content-type="genus-species">Staphylococcus aureus</named-content> populations based on <italic>spa</italic> polymorphisms</article-title>. <source>BMC Microbiol</source>
<volume>7</volume>:<fpage>98</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2180-7-98</pub-id>.<pub-id pub-id-type="pmid">17967176</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossney</surname><given-names>AS</given-names></name>, <name><surname>Shore</surname><given-names>AC</given-names></name>, <name><surname>Morgan</surname><given-names>PM</given-names></name>, <name><surname>Fitzgibbon</surname><given-names>MM</given-names></name>, <name><surname>O'Connell</surname><given-names>B</given-names></name>, <name><surname>Coleman</surname><given-names>DC</given-names></name></person-group>
<year>2007</year>
<article-title>The emergence and importation of diverse genotypes of methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> (MRSA) harboring the Panton-Valentine leukocidin gene (<italic>pvl</italic>) reveal that <italic>pvl</italic> is a poor marker for community-acquired MRSA strains in Ireland</article-title>. <source>J Clin Microbiol</source>
<volume>45</volume>:<fpage>2554</fpage>&#8211;<lpage>2563</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.00245-07</pub-id>.<pub-id pub-id-type="pmid">17581935</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monecke</surname><given-names>S</given-names></name>, <name><surname>Jatzwauk</surname><given-names>L</given-names></name>, <name><surname>Weber</surname><given-names>S</given-names></name>, <name><surname>Slickers</surname><given-names>P</given-names></name>, <name><surname>Ehricht</surname><given-names>R</given-names></name></person-group>
<year>2008</year>
<article-title>DNA microarray-based genotyping of methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> strains from Eastern Saxony</article-title>. <source>Clin Microbiol Infect</source>
<volume>14</volume>:<fpage>534</fpage>&#8211;<lpage>545</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1469-0691.2008.01986.x</pub-id>.<pub-id pub-id-type="pmid">18373691</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monecke</surname><given-names>S</given-names></name>, <name><surname>Slickers</surname><given-names>P</given-names></name>, <name><surname>Ehricht</surname><given-names>R</given-names></name></person-group>
<year>2008</year>
<article-title>Assignment of <named-content content-type="genus-species">Staphylococcus aureus</named-content> isolates to clonal complexes based on microarray analysis and pattern recognition</article-title>. <source>FEMS Immunol Med Microbiol</source>
<volume>53</volume>:<fpage>237</fpage>&#8211;<lpage>251</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1574-695X.2008.00426.x</pub-id>.<pub-id pub-id-type="pmid">18507678</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodford</surname><given-names>N</given-names></name>, <name><surname>Watson</surname><given-names>AP</given-names></name>, <name><surname>Patel</surname><given-names>S</given-names></name>, <name><surname>Jevon</surname><given-names>M</given-names></name>, <name><surname>Waghorn</surname><given-names>DJ</given-names></name>, <name><surname>Cookson</surname><given-names>BD</given-names></name></person-group>
<year>1998</year>
<article-title>Heterogeneous location of the <italic>mupA</italic> high-level mupirocin resistance gene in <named-content content-type="genus-species">Staphylococcus aureus</named-content></article-title>. <source>J Med Microbiol</source>
<volume>47</volume>:<fpage>829</fpage>&#8211;<lpage>835</lpage>. doi:<pub-id pub-id-type="doi">10.1099/00222615-47-9-829</pub-id>.<pub-id pub-id-type="pmid">9736165</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udo</surname><given-names>EE</given-names></name>, <name><surname>Jacob</surname><given-names>LE</given-names></name></person-group>
<year>1998</year>
<article-title>Conjugative transfer of high-level mupirocin resistance and the mobilization of non-conjugative plasmids in <named-content content-type="genus-species">Staphylococcus aureus</named-content></article-title>. <source>Microb Drug Resist</source>
<volume>4</volume>:<fpage>185</fpage>&#8211;<lpage>193</lpage>. doi:<pub-id pub-id-type="doi">10.1089/mdr.1998.4.185</pub-id>.<pub-id pub-id-type="pmid">9818970</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>SK</given-names></name>, <name><surname>Sakoulas</surname><given-names>G</given-names></name>, <name><surname>Wennersten</surname><given-names>C</given-names></name>, <name><surname>Eliopoulos</surname><given-names>GM</given-names></name>, <name><surname>Moellering</surname><given-names>RC</given-names><suffix>Jr</suffix></name>, <name><surname>Ferraro</surname><given-names>MJ</given-names></name>, <name><surname>Gold</surname><given-names>HS</given-names></name></person-group>
<year>2002</year>
<article-title>Linezolid resistance in <named-content content-type="genus-species">Staphylococcus aureus</named-content>: characterization and stability of resistant phenotype</article-title>. <source>J Infect Dis</source>
<volume>186</volume>:<fpage>1603</fpage>&#8211;<lpage>1607</lpage>. doi:<pub-id pub-id-type="doi">10.1086/345368</pub-id>.<pub-id pub-id-type="pmid">12447736</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutherford</surname><given-names>K</given-names></name>, <name><surname>Parkhill</surname><given-names>J</given-names></name>, <name><surname>Crook</surname><given-names>J</given-names></name>, <name><surname>Horsnell</surname><given-names>T</given-names></name>, <name><surname>Rice</surname><given-names>P</given-names></name>, <name><surname>Rajandream</surname><given-names>MA</given-names></name>, <name><surname>Barrell</surname><given-names>B</given-names></name></person-group>
<year>2000</year>
<article-title>Artemis: sequence visualization and annotation</article-title>. <source>Bioinformatics</source>
<volume>16</volume>:<fpage>944</fpage>&#8211;<lpage>945</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/16.10.944</pub-id>.<pub-id pub-id-type="pmid">11120685</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>J</given-names></name>, <name><surname>Strommenger</surname><given-names>B</given-names></name>, <name><surname>Steglich</surname><given-names>M</given-names></name>, <name><surname>Zimmermann</surname><given-names>O</given-names></name>, <name><surname>Fenner</surname><given-names>I</given-names></name>, <name><surname>Lensing</surname><given-names>C</given-names></name>, <name><surname>Dagwadordsch</surname><given-names>U</given-names></name>, <name><surname>Kekule</surname><given-names>AS</given-names></name>, <name><surname>Werner</surname><given-names>G</given-names></name>, <name><surname>Layer</surname><given-names>F</given-names></name></person-group>
<year>2015</year>
<article-title>Linezolid resistance in clinical isolates of <named-content content-type="genus-species">Staphylococcus epidermidis</named-content> from German hospitals and characterization of two <italic>cfr</italic>-carrying plasmids</article-title>. <source>J Antimicrob Chemother</source>
<volume>70</volume>:<fpage>1630</fpage>&#8211;<lpage>1638</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkv025</pub-id>.<pub-id pub-id-type="pmid">25740949</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrenberg</surname><given-names>C</given-names></name>, <name><surname>Aarestrup</surname><given-names>FM</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>IS<italic>21-558</italic> insertion sequences are involved in the mobility of the multiresistance gene <italic>cfr</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>51</volume>:<fpage>483</fpage>&#8211;<lpage>487</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01340-06</pub-id>.<pub-id pub-id-type="pmid">17145796</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Wu</surname><given-names>W</given-names></name>, <name><surname>Ni</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Cao</surname><given-names>B</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name></person-group>
<year>2013</year>
<article-title>Linezolid-resistant clinical isolates of enterococci and <named-content content-type="genus-species">Staphylococcus cohnii</named-content> from a multicentre study in China: molecular epidemiology and resistance mechanisms</article-title>. <source>Int J Antimicrob Agents</source>
<volume>42</volume>:<fpage>317</fpage>&#8211;<lpage>321</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2013.06.008</pub-id>.<pub-id pub-id-type="pmid">23880167</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>RE</given-names></name>, <name><surname>Flamm</surname><given-names>RK</given-names></name>, <name><surname>Hogan</surname><given-names>PA</given-names></name>, <name><surname>Ross</surname><given-names>JE</given-names></name>, <name><surname>Jones</surname><given-names>RN</given-names></name></person-group>
<year>2014</year>
<article-title>Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>58</volume>:<fpage>1243</fpage>&#8211;<lpage>1247</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.02112-13</pub-id>.<pub-id pub-id-type="pmid">24323470</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lincopan</surname><given-names>N</given-names></name>, <name><surname>de Almeida</surname><given-names>LM</given-names></name>, <name><surname>Elmor de Araujo</surname><given-names>MR</given-names></name>, <name><surname>Mamizuka</surname><given-names>EM</given-names></name></person-group>
<year>2009</year>
<article-title>Linezolid resistance in <named-content content-type="genus-species">Staphylococcus epidermidis</named-content> associated with a G2603T mutation in the 23S rRNA gene</article-title>. <source>Int J Antimicrob Agents</source>
<volume>34</volume>:<fpage>281</fpage>&#8211;<lpage>282</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2009.02.023</pub-id>.<pub-id pub-id-type="pmid">19376688</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ban</surname><given-names>N</given-names></name>, <name><surname>Nissen</surname><given-names>P</given-names></name>, <name><surname>Hansen</surname><given-names>J</given-names></name>, <name><surname>Moore</surname><given-names>PB</given-names></name>, <name><surname>Steitz</surname><given-names>TA</given-names></name></person-group>
<year>2000</year>
<article-title>The complete atomic structure of the large ribosomal subunit at 2.4 A resolution</article-title>. <source>Science</source>
<volume>289</volume>:<fpage>905</fpage>&#8211;<lpage>920</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.289.5481.905</pub-id>.<pub-id pub-id-type="pmid">10937989</pub-id></mixed-citation></ref></ref-list></back></article>